For the latest ecancer COVID-19 resources, click on this link

News

ecancer sources relevant oncology news from key institutes, journals, governments, NGOs and charities, along with commissioned pieces from our dedicated news team.
Latest news
ASCO 2021: Newly approved drug effective against lung cancer caused by genetic mutation
ASCO 2021: Newly approved drug effective against lung cancer caused by genetic mutation
Researchers find evidence that diet can alter the microbiome to affect breast cancer risk
Researchers find evidence that diet can alter the microbiome to affect breast cancer risk
European Commission approves nivolumab plus ipilimumab as first-line treatment for mesothelioma
European Commission approves nivolumab plus ipilimumab as first-line treatment for mesothelioma
Novel antibody drug wakes up the body's defence system in advanced-stage cancer
Novel antibody drug wakes up the body's defence system in advanced-stage cancer
ASCO 2021: Breast cancer patients embrace integrative health during treatment
ASCO 2021: Breast cancer patients embrace integrative health during treatment
Ageing impairs anti-tumour T-cell response via mitochondria dysfunction
Ageing impairs anti-tumour T-cell response via mitochondria dysfunction
ASCO 2021: No survival difference for frontline combination regimens in real world intermediate-risk and poor-risk clear cell RCC
ASCO 2021: No survival difference for frontline combination regimens in real world intermediate-risk...
Analysing tumour microenvironment at single cell level sheds light on metastatic melanoma outcomes
Analysing tumour microenvironment at single cell level sheds light on metastatic melanoma outcomes
ASCO 2021: Immune therapy after surgery lowers relapse risk in patients with high-risk melanoma
ASCO 2021: Immune therapy after surgery lowers relapse risk in patients with high-risk melanoma
ASCO 2021: Choice of first-line platinum regimen does not significantly impact efficacy of second-line immunotherapy in advanced bladder cancer
ASCO 2021: Choice of first-line platinum regimen does not significantly impact efficacy of second-li...

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation